The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Chabrol, H.
* Articles by Peresson, G.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Chabrol, H.
* Articles by Peresson, G.
Am J Psychiatry 155:995, July 1998
©Copyright 1998 American Psychiatric Association


Letter to the Editor

Pulse Clomipramine for Depressed Adolescents

Henri Chabrol, M.D., Ph.D., and Genevieve Peresson, M.D.
Toulouse, France

TO THE EDITOR: Dr. Sallee and his colleagues (1) concluded that "the rate of response to pulse clomipramine was robust." However, it is difficult to accept their conclusion. Indeed, when responders were defined by a decrease of 50% or more from baseline in Hamilton depression scale scores, there were seven responders to clomipramine and three responders to the placebo, and this difference did not reach statistical significance. Moreover, this difference should be paralleled with the rate of prior treatment in the two groups: three of the clomipramine-treated patients versus seven of the placebo-treated patients had received previous treatment. Therefore, the higher rate of treatment-resistant depression in the placebo group might account for the difference between the two groups in rates of responders. This hypothesis seems to be confirmed by the low response rate to a subsequent open-label treatment with various selective serotonin reuptake inhibitors (SSRIs) among placebo-treated patients.

REFERENCES

  1. Sallee FR, Vrindavanam NS, Deas-Nesmith D, Carson SW, Sethur~aman G: Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial. Am J Psychiatry 1997; 154:668–673[Abstract]



This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
A. Reichenberg, M. Weiser, M. A. Rapp, J. Rabinowitz, A. Caspi, J. Schmeidler, H. Y. Knobler, G. Lubin, D. Nahon, P. D. Harvey, et al.
Elaboration on Premorbid Intellectual Performance in Schizophrenia: Premorbid Intellectual Decline and Risk for Schizophrenia
Arch Gen Psychiatry, December 1, 2005; 62(12): 1297 - 1304.
[Abstract] [Full Text] [PDF]


This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Chabrol, H.
* Articles by Peresson, G.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Chabrol, H.
* Articles by Peresson, G.


Get information about faster international access.

Privacy Policy

Copyright © 1998 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org